Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT
49.80
+0.60 (1.22%)
At close: Nov 14, 2024
Navana Pharmaceuticals Revenue
Navana Pharmaceuticals had revenue of 1.75B BDT in the quarter ending March 31, 2024, with 16.38% growth. This brings the company's revenue in the last twelve months to 6.50B, up 22.00% year-over-year. In the fiscal year ending June 30, 2023, Navana Pharmaceuticals had annual revenue of 5.71B with 19.91% growth.
Revenue (ttm)
6.50B
Revenue Growth
+22.00%
P/S Ratio
0.77
Revenue / Employee
1.67M
Employees
4,143
Market Cap
5.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 5.71B | 947.45M | 19.91% |
Jun 30, 2022 | 4.76B | 1.15B | 31.95% |
Jun 30, 2021 | 3.61B | 457.57M | 14.53% |
Jun 30, 2020 | 3.15B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition